Matches in SemOpenAlex for { <https://semopenalex.org/work/W2146376238> ?p ?o ?g. }
- W2146376238 endingPage "183" @default.
- W2146376238 startingPage "172" @default.
- W2146376238 abstract "Immune thrombocytopenic purpura (ITP) is a relatively common blood disorder related to the production of anti-platelet antibodies. It is now clear that platelet production is also substantially impaired in most patients. After the cloning of TPO and analogs, there were reported therapeutic successes in a few refractory ITP patients, but neutralizing antibodies led to the withdrawal of first-generation thrombopoietic growth factor from development. Second-generation thrombopoietic growth factors are now available that stimulate c-mpl but share no homology with the native hormone. Second-generation thrombopoietic growth factors have shown responses in 50-80% of ITP patients with only modest toxicity, and thus they offer another therapeutic option. The first of these agents to enter clinical trials and to be approved by the FDA is romiplostim, a once weekly subcutaneous peptibody. Eltrombopag is the second FDA-approved thrombopoietic growth factor and has the advantage of oral formulation. Some concerns persist on the potential of these agents to cause increased thrombosis risk, rebound thrombocytopenia on drug withdrawal, reticulin fibrosis of the marrow, and induction of malignancy, but these have not emerged as major problems in clinical trials." @default.
- W2146376238 created "2016-06-24" @default.
- W2146376238 creator A5037844664 @default.
- W2146376238 creator A5045714102 @default.
- W2146376238 creator A5081093007 @default.
- W2146376238 date "2011-03-01" @default.
- W2146376238 modified "2023-09-26" @default.
- W2146376238 title "Thrombopoietic growth factors in the treatment of immune thrombocytopenic purpura" @default.
- W2146376238 cites W112965007 @default.
- W2146376238 cites W147888456 @default.
- W2146376238 cites W1549783447 @default.
- W2146376238 cites W1561516029 @default.
- W2146376238 cites W1890881866 @default.
- W2146376238 cites W1903176849 @default.
- W2146376238 cites W1949405420 @default.
- W2146376238 cites W1965375035 @default.
- W2146376238 cites W1971846792 @default.
- W2146376238 cites W1971957984 @default.
- W2146376238 cites W1974301854 @default.
- W2146376238 cites W1980002878 @default.
- W2146376238 cites W1981111597 @default.
- W2146376238 cites W1981471739 @default.
- W2146376238 cites W1983612778 @default.
- W2146376238 cites W1985580181 @default.
- W2146376238 cites W1988310677 @default.
- W2146376238 cites W1989118573 @default.
- W2146376238 cites W1991302255 @default.
- W2146376238 cites W1993960588 @default.
- W2146376238 cites W1994397765 @default.
- W2146376238 cites W1998402062 @default.
- W2146376238 cites W2000583684 @default.
- W2146376238 cites W2000745319 @default.
- W2146376238 cites W2012780133 @default.
- W2146376238 cites W2013946336 @default.
- W2146376238 cites W2014207233 @default.
- W2146376238 cites W2017955228 @default.
- W2146376238 cites W2019858566 @default.
- W2146376238 cites W2025122282 @default.
- W2146376238 cites W2038818733 @default.
- W2146376238 cites W2044592287 @default.
- W2146376238 cites W2052378439 @default.
- W2146376238 cites W2056147490 @default.
- W2146376238 cites W2056173679 @default.
- W2146376238 cites W2058437162 @default.
- W2146376238 cites W2061382718 @default.
- W2146376238 cites W2062525245 @default.
- W2146376238 cites W2066976900 @default.
- W2146376238 cites W2070075266 @default.
- W2146376238 cites W2079807050 @default.
- W2146376238 cites W2084718852 @default.
- W2146376238 cites W2085583977 @default.
- W2146376238 cites W2087844863 @default.
- W2146376238 cites W2092982665 @default.
- W2146376238 cites W2096984260 @default.
- W2146376238 cites W2097875686 @default.
- W2146376238 cites W2103818290 @default.
- W2146376238 cites W2119920607 @default.
- W2146376238 cites W2121116928 @default.
- W2146376238 cites W2133900940 @default.
- W2146376238 cites W2135406252 @default.
- W2146376238 cites W2139745353 @default.
- W2146376238 cites W2142812740 @default.
- W2146376238 cites W2143531841 @default.
- W2146376238 cites W2145439228 @default.
- W2146376238 cites W2155645351 @default.
- W2146376238 cites W2161118718 @default.
- W2146376238 cites W2167810526 @default.
- W2146376238 cites W2169047364 @default.
- W2146376238 cites W2242685879 @default.
- W2146376238 cites W2254065586 @default.
- W2146376238 cites W2317912629 @default.
- W2146376238 cites W2330913380 @default.
- W2146376238 cites W2429532617 @default.
- W2146376238 cites W2557540977 @default.
- W2146376238 cites W2591949526 @default.
- W2146376238 cites W28400798 @default.
- W2146376238 cites W29651041 @default.
- W2146376238 cites W2987041532 @default.
- W2146376238 cites W4244215862 @default.
- W2146376238 cites W6605387 @default.
- W2146376238 doi "https://doi.org/10.1016/j.critrevonc.2010.03.001" @default.
- W2146376238 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20378370" @default.
- W2146376238 hasPublicationYear "2011" @default.
- W2146376238 type Work @default.
- W2146376238 sameAs 2146376238 @default.
- W2146376238 citedByCount "15" @default.
- W2146376238 countsByYear W21463762382013 @default.
- W2146376238 countsByYear W21463762382014 @default.
- W2146376238 countsByYear W21463762382015 @default.
- W2146376238 countsByYear W21463762382016 @default.
- W2146376238 countsByYear W21463762382019 @default.
- W2146376238 countsByYear W21463762382021 @default.
- W2146376238 crossrefType "journal-article" @default.
- W2146376238 hasAuthorship W2146376238A5037844664 @default.
- W2146376238 hasAuthorship W2146376238A5045714102 @default.
- W2146376238 hasAuthorship W2146376238A5081093007 @default.
- W2146376238 hasConcept C109159458 @default.
- W2146376238 hasConcept C126322002 @default.